Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 1;21(4):386-403.
doi: 10.1016/j.cbpra.2013.10.002.

Implementing Behavioral Activation and Life-Steps for Depression and HIV Medication Adherence in a Community Health Center

Affiliations

Implementing Behavioral Activation and Life-Steps for Depression and HIV Medication Adherence in a Community Health Center

Jessica F Magidson et al. Cogn Behav Pract. .

Abstract

Antiretroviral therapy to treat HIV/AIDS has substantially improved clinical outcomes among patients living with HIV/AIDS, but only in the presence of very consistent adherence. One of the most prevalent and impactful individual-level predictors of poor adherence is depressive symptoms, even at subthreshold levels. Evidence-based cognitive behavioral interventions exist to address improvements in depressive symptoms and adherence in this population, yet these techniques have largely been designed and tested as individual treatments for delivery in mental health settings. This presents a significant challenge when transporting these techniques to medical settings where other formats for delivery may be more appropriate (i.e., groups, less frequent visits) and few hands-on resources exist to guide this process. As such, primary aims of this study were to adapt and implement evidence-based cognitive behavioral techniques for depression (behavioral activation; BA) and HIV medication adherence (Life-Steps) that have potential for dissemination in an outpatient community health center. The intervention incorporated feedback from health center staff and utilized a modular, group format that did not rely on sequential session attendance. Feasibility was examined over 8 weeks (n = 13). Preliminary effects on depression, health-related quality of life, and medication adherence were examined and exit interviews were conducted with a subset of participants (n = 4) to inform future modifications. Treatment descriptions and recommendations for effective clinical implementation based on patient and clinician feedback are provided along with case material of two individual patients and an example group session. Current efforts are an important next step for disseminating evidence-based techniques for depression and HIV medication adherence to community health center or AIDS service organization settings.

Keywords: CBT; HIV medication adherence; behavioral activation; community health center; depression.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Depiction of BA treatment rationale reviewed at the start of each session. This was based upon the BA treatment rationale depicted in Act Healthy (Daughters et al., 2010). Specifically, this figure is introduced to patients step-by-step illustrating how the treatment is meant to break the negative cycle (i.e., where the “x” is) and start a new more positive cycle.
Figure 2
Figure 2
Activity monitoring and scheduling forms introduced and reviewed at each session. This form was adapted from Lejuez et al. (2011).
Figure 3
Figure 3
Life Areas, Goals, and Activities Inventory. Note that only one table per life area is depicted here due to space constraints; however, participants could work on more than one goal in each life area.

Similar articles

Cited by

References

    1. Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug and Alcohol Dependence. 2006;81(3):313–322. - PubMed
    1. Aharonovich E, Nunes E, Hasin D. Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug and Alcohol Dependence. 2003;71(2):207–211. - PMC - PubMed
    1. Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–387. - PMC - PubMed
    1. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–1183. - PubMed
    1. Berg C, Raminani S, Greer J, Harwood M, Safren S. Participants’ perspectives on cognitive-behavioral therapy for adherence and depression in HIV. Psychotherapy Research. 2008;18(3):271–280. - PMC - PubMed

LinkOut - more resources